PCSK9 inhibitors for acute coronary syndrome: the era of early implementation

Overview of attention for article published in Frontiers in Cardiovascular Medicine, May 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 14 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,959 followers.

PCSK9 inhibitors for acute coronary syndrome: the era of early implementation https://t.co/UlcIstlul1

19 May 2023

Reply Repost Favourite

New Research: PCSK9 inhibitors for acute coronary syndrome: the era of early implementation: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, a new cholesterol-lowering strategy, can decrease low-density lipoprotein… #cardiovascular https:

02 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.